An Investigation into the Ability of AAGP® to Protect Against UVA and UVC Stimulated Cell Death in Hela Cells and Adult Primary Fibroblasts

Background image

Hussein and Palumbo, February 2007


Exposure of skin cells to ultraviolet light has been found to result in protein and DNA damage and production of inflammatory mediators, which can ultimately lead to increased apoptotic cell death. The aim of this investigation was to explore AAGPs® potential to protect both Hela and Adult skin fibroblasts against high intensity UVA and UVC wavelengths so as to both examine its potential and also begin to elucidate its mechanism of action in cell protection.


Human adult primary skin fibroblasts and Hela cells were seeded in 96 well plates at a concentration of 9000 – 15000 cells per well. 24 hours after seeding either 0 or 5mg/ml AAGP® were added to the plates, with two plates being used for each concentration. All cell populations were then exposed to UVC (254nm) at 400J/m2 or UVA (365nm) at 10J/cm2. Post UVA/UVC exposure 5mg/ml AAGP® was again added to the non-control group.

Cell numbers were calculated for both the control and AAGP® populations at 1, 24 and 48 hours post UVA or UVC exposure using Trypan blue (2 consecutive counts per sample). To ensure that AAGP® was having no affect on cell proliferation, cell-doubling time was calculated for both cell lines with and without the presence of AAGP®.


The most prominent results were found in human adult fibroblasts where AAGP® decreased UVA induced cell death by 25% (24 hours post exposure) in comparison to control cells (figure1). When exposed to UVC light the presence of AAGP® decreased cell death by 41%, 54% and 25% – 1, 24 and 48 hours post exposure respectively – in comparison to the control (figure 2).

Line graph image

Figure 1: Effect of AAGP® Treatment on UVC Exposed Adult Skin Fibroblasts.

Line graph image
Figure 2: Effect of AAGP® Treatment on UVA Exposed Adult Skin Fibroblasts.

AAGP® also had no affect on cell doubling time in either cell line. In addition the cell doubling time of human adult fibroblasts was found to be 120 hours showing the affects above were due to cell protection rather than increased proliferation.

Bar graph image
Figure 3: Effect of AAGP® Treatment on Cell Doubling Time.


It can be concluded that AAGP® appears to protect human adult fibroblasts against both UVC and UVA induced cell death. This further suggests that AAGPs® mechanism of cell protection may be anti-inflammatory.